MultiPlan Corporation Reports Better-Than-Expected Revenue Growth, adjusted EBITDA for Q1 2022

By Alan Hatfield Healthcare data analytics and cost management solutions provider MultiPlan Corporation (NYSE: MPLN) beat prior guidance on both revenue and adjusted EBITDA. Revenue reached $298 million during the period, representing a 16.9% increase over Q1 of the...